CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Truist Financial Corporation from $33.00 to $38.00. They now have a "buy" rating on the stock.
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting [Yahoo! Finance]
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
Form 4 Centessa Pharmaceuticals For: Feb 02 Filed by: Kanes Stephen
Form 4 Centessa Pharmaceuticals For: Feb 02 Filed by: Crowley John J
Form 4 Centessa Pharmaceuticals For: Feb 02 Filed by: Deferiere Raphael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.